RadNet Inc (FRA:PQIA) Stock Price, Trades & News

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.

Financial Strength

4/10

Name	Current	Vs Industry
Cash-To-Debt	0.24
Equity-to-Asset	0.28
Debt-to-Equity	1.79
Debt-to-EBITDA	5.97
Interest Coverage	1.15
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	1.91	Distress Grey Safe
Beneish M-Score	-2.77	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

8/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	2.8
	3-Year EBITDA Growth Rate	-4.9
	3-Year FCF Growth Rate	34.3
	3-Year Book Growth Rate	34.6
	Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank	47.21
	Future 3-5Y Total Revenue Growth Rate Estimate	14.33

Momentum Rank

4/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	80.86
	9-Day RSI	77.62
	14-Day RSI	72.64
	3-1 Month Momentum %	-4.91
	6-1 Month Momentum %	-29.1
	12-1 Month Momentum %	-6.52

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.17
	Quick Ratio	1.17
	Cash Ratio	0.72
	Days Sales Outstanding	34.72
	Days Payable	69.16

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	3-Year Average Share Buyback Ratio	-10.3
	Shareholder Yield %	-2.54

Profitability Rank

5/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	11.32
	Operating Margin %	3.78
	Net Margin %	-0.66
	EBITDA Margin %	15.11
	FCF Margin %	4.78
	OCF Margin %	15.71
	ROE %	-1.4
	ROA %	-0.39
	ROIC %	2.03
	3-Year ROIIC %	0.82
	ROC (Joel Greenblatt) %	6.97
	ROCE %	3.35
	Years of Profitability over Past 10-Year	8
	Moat Score	5
	Tariff Resilience Score	6

GF Value Rank

9/10

	Name	Current	Vs Industry		Vs History
	Forward PE Ratio	108.98
	PE Ratio without NRI	287.29
	Shiller PE Ratio	585.11
	Price-to-Owner-Earnings	63.43
	PS Ratio	2.47
	PB Ratio	5.01
	Price-to-Free-Cash-Flow	51.34
	Price-to-Operating-Cash-Flow	15.67
	EV-to-EBIT	69.95
	EV-to-EBITDA	22.14
	EV-to-Forward-EBITDA	11.96
	EV-to-Revenue	3.34
	EV-to-FCF	70.35
	Price-to-GF-Value	1.03
	Price-to-Projected-FCF	3.77
	Price-to-Median-PS-Value	2.91
	Earnings Yield (Greenblatt) %	1.43
	FCF Yield %	1.88
	Forward Rate of Return (Yacktman) %	-4.62

Financials (Next Earnings Date:2026-08-11 Est.)

Annual Quarterly TTM

FRA:PQIA's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

RadNet Inc Executives

Details

GF Value™: €58.62

FRA:PQIA

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 2 Severe warning signs with PQIA. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	1,843.116
	EPS (TTM) (€)	-0.156
	Beta	1.298
	3-Year Sharpe Ratio	0.57
	3-Year Sortino Ratio	1
	Volatility %	37.78
	14-Day RSI	72.64
	14-Day ATR (€)	1.358256
	20-Day SMA (€)	51.2665
	12-1 Month Momentum %	-6.52
	52-Week Range (€)	43.85 - 74
	Shares Outstanding (Mil)	78.63

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	5
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

RadNet Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

RadNet Inc Stock Events

Financials Calendars

Event	Date	Price (€)
Third quarter earnings conference call for 2026	2026-11-10 10:30	In 126 days
Third quarter earnings results for 2026	2026-11-10	In 125 days
Second quarter earnings conference call for 2026	2026-08-11 10:30	In 35 days
Second quarter earnings results for 2026	2026-08-11	In 34 days
General meeting for 2026	2026-06-02 10:00	47.44 (+0.00%)
First quarter earnings conference call for 2026	2026-05-11 07:30	48.67 (+0.00%)
First quarter earnings results for 2026	2026-05-11	48.67 (+0.00%)
KeyBanc Capital Markets Healthcare Forum	2026-03-17 16:30	54.50 (+0.00%)
28th Annual Barclays Global Healthcare Conference	2026-03-12 08:00	52.00 (+0.00%)
RadNet Galaxy Conference Call	2026-03-05 10:30	62.50 (+1.63%)

Show

Entries

RadNet Inc Frequently Asked Questions

What is RadNet Inc(FRA:PQIA)'s stock price today?

The current price of FRA:PQIA is €59.48. The 52 week high of FRA:PQIA is €74.00 and 52 week low is €43.85.

When is next earnings date of RadNet Inc(FRA:PQIA)?

The next earnings date of RadNet Inc(FRA:PQIA) is 2026-08-11 Est..

Does RadNet Inc(FRA:PQIA) pay dividends? If so, how much?

RadNet Inc(FRA:PQIA) does not pay dividend.

Press Release

	Subject	Date
	AI Healthcare Funding Surges as Real-World Rollouts Hit Pharmacies, Hospitals, and Providers	2025-06-17
	Ketryx Announces DeepHealth Selected Its Software to Accelerate AI-Powered Health Informatics Innovation	2024-12-04
	RADNET ANNOUNCES PROPOSED $175 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK	2023-06-13
	RadNet Launches the Enhanced Breast Cancer Detection Program, Providing Women in New York and New Jersey a New State-of-the-Art Solution Powered by Artificial Intelligence	2023-02-08
	Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial Intelligence	2023-02-06
	Delaware Imaging Network Launches the Enhanced Breast Cancer Detection Program, Providing Women a New State-of-the-Art Solution Powered by Artificial Intelligence	2022-12-05
	Open System Imaging Deploys eRAD RIS	2022-08-09
	RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools	2022-07-15
	RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools	2022-07-05
	RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools	2022-06-25

10/Page

Articles on RadNet Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.